TINA DOMINEY: Open Payments
NPI 1962123505 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 20 payments from 10 companies in 2025. Trend: 2023 $140 · 2024 $514 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $138 |
| Lilly USA, LLC | 3 | $73 |
| CeQur Corporation | 1 | $63 |
| ABBVIE INC. | 2 | $46 |
| Medtronic, Inc. | 1 | $37 |
| Dexcom, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $18 |
Products named: MOUNJARO, Ozempic, CeQur Simplicity, UBRELVY, MINIMED 780G, Dexcom G6 Transmitter, STRENSIQ, TERIPARATIDE.
Industry payments across MD — which companies pay providers there.
